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Background: Magnetic liposomes (MLs) are phospholipid vesicles that encapsulate magnetic 
and/or paramagnetic nanoparticles. They are applied as contrast agents for magnetic resonance 
imaging (MRI). MLs have an advantage over free magnetic nanocores, in that various func-
tional groups can be attached to the surface of liposomes for ligand-specific targeting. We have 
synthesized PEG-coated sterically-stabilized magnetic liposomes (sMLs) containing ultrasmall 
superparamagnetic iron oxides (USPIOs) with the aim of generating stable liposomal carriers 
equipped with a high payload of USPIOs for enhanced MRI contrast.
Methods: Regarding iron oxide nanoparticles, we have applied two different commercially 
available surface-coated USPIOs; sMLs synthesized and loaded with USPIOs were compared 
in terms of magnetization and colloidal stability. The average diameter size, morphology, 
phospholipid membrane fluidity, and the iron content of the sMLs were determined by dynamic 
light scattering (DLS), transmission electron microscopy (TEM), fluorescence polarization, 
and absorption spectroscopy, respectively. A colorimetric assay using potassium thiocyanate 
(KSCN) was performed to evaluate the encapsulation efficiency (EE%) to express the amount 
of iron enclosed into a liposome. Subsequently, MRI measurements were carried out in vitro in 
agarose gel phantoms to evaluate the signal enhancement on T1- and T2-weighted sequences 
of sMLs. To monitor the biodistribution and the clearance of the particles over time in vivo, 
sMLs were injected in wild type mice.
Results: DLS revealed a mean particle diameter of sMLs in the range between 100 and 200 nm, 
as confirmed by TEM. An effective iron oxide loading was achieved just for one type of USPIO, 
with an EE% between 74% and 92%, depending on the initial Fe concentration (being higher 
for lower amounts of Fe). MRI measurements demonstrated the applicability of these nano-
structures as MRI probes.
Conclusion: Our results show that the development of sMLs is strictly dependent on the physi-
cochemical characteristics of the nanocores. Once established, sMLs can be further modified to 
enable noninvasive targeted molecular imaging.
Keywords: magnetic liposomes, fluorescence polarization, biodistribution, MRI contrast 
agent
Introduction
Liposomes are vesicular systems that are formed when phospholipids are dispersed in 
an aqueous solution and self-assemble into one (unilamellar) or more (oligolamellar, 
multilamellar) concentric bilayers surrounding an aqueous core. For several years, 
liposomes have occupied the center of interest because of their multiple advantages.1,2 
One is their capability of encapsulating polar drugs or contrast agents in their aque-
ous inner core. In particular, their biocompatibility, which is defined as the quality of 
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having no toxic or injurious effects on biological systems, 
enables them to be utilized as carriers, either for therapeutics 
or diagnostics in vivo.3–6
In this study, the synthesis of liposomes that offer the 
opportunity for targeted, noninvasive diagnosis by magnetic 
resonance imaging (MRI) will be described. For this purpose, 
iron oxide nanoparticles can be encapsulated into phospholipid 
vesicles to develop liposomal contrast agents (ie, magnetic 
liposomes [MLs]).7–11 Here, we have focused our attention 
on ultrasmall superparamagnetic iron oxide nanoparticles 
(USPIOs), which have a hydrodynamic diameter of less than 
50 nm. In contrast to superparamagnetic iron oxide nanopar-
ticles (SPIOs; diameters between 70 and 150 nm), which are 
used as T2 contrast agents, USPIOs additionally show a T1 
contrast when applied in moderate concentrations.12–14 More 
precisely, USPIOs affect the relaxivity of nearby water protons 
by decreasing their T1 and T2 relaxation times at nanomolar 
concentrations. This can be seen as increased signal   intensity 
(hyperintense T1 effect) when applying a T1-weighted 
sequence, and as decreased signal intensity (hypointense 
T2 effect) when using T2-weighted sequences.15–17 USPIOs 
consist of a magnetic core that is usually coated by various 
materials (eg, citrate, dextran, or oleic acid) to improve the 
solubility and the stability of the nanoparticles in colloidal 
suspension.18,19 However, the coating is not always strongly 
retained by the core, and due to gravitational forces, USPIOs 
dispersed in an aqueous solution tend to aggregate and 
  precipitate, resulting in a destabilization of the suspension.20 
Moreover, the lack of an efficient coating of the magnetic cores 
increases their susceptibility to aging effects – which can affect 
the surfaces via oxidation of magnetite (Fe3O4) and maghemite 
(–Fe2O3) – resulting in a particle with completely different 
  physicochemical and magnetic properties than expected.21 
To overcome these problems, USPIOs can be captured into 
liposomes to protect them from both aggregation and oxidation 
phenomena. Even more importantly, if a high payload of iron is 
packed into a liposome, the resulting magnetic dipole moment 
will be markedly enhanced, and this will lead to a stronger MRI 
signal, relative to a single magnetic core.12,22 This particular 
feature makes MLs suitable MRI contrast agents for several 
biomedical applications.16 However, for in vivo applications, 
the circulation time of MLs in the bloodstream should be long 
enough to ameliorate target-ligand interaction. This goal can be 
achieved by steric stabilization of the liposomes (eg, by adding 
a poly-ethylene glycol [PEG]-based phospholipid to the lipid 
formulation). Lipid-anchored PEG stabilizes the liposome 
and prevents the rapid recognition and consequent uptake of 
MLs via the mononuclear phagocyte system.23–25 In addition, 
functionalized derivatives of PEG-lipids can be used for the 
convenient coupling of targeting sequences to the surface of 
the liposomes to achieve specific cellular recognition.
Here, we have synthesized PEG-coated stealth   magnetic 
liposomes (sMLs) by evaluating two different types of 
  commercially available USPIOs. We have analyzed the 
chemical and physical characteristics of the sMLs,   including 
iron oxide loading capacity, encapsulation efficiency,   particle 
size, morphology, zeta potential, and the influence of the 
magnetic cores on phospholipid membrane fluidity. In 
  addition, the magnetic properties of sMLs were   investigated 
in vitro in agarose gel phantoms and in vivo in wild type mice, 
following the biodistribution and the clearance of the particles 
over time. Accordingly, the effects of the liposomal contrast 
agents on both negative and positive MRI signal enhance-
ment were evaluated with the goal of establishing an optimal 
formulation for the synthesis of targeted,   multifunctional 
nanoconstructs.
Material and methods
Materials
The following lipids were used for the synthesis of sMLs: 
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC); 
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
(methoxy [polyethylene glycol]-2000) (DSPE-Peg-2000); 
and cholesterol (CH) were purchased from Avanti Polar 
Lipids Inc (Alabaster, AL).
Iron oxides (Fe3O4) were used for encapsulation in sMLs; 
magnetite grains coated with a polar surfactant (EMG 
1500) were purchased from FerroTec Corp (Tokyo, Japan), 
and dextran-coated USPIOs (Molday Ion, catalog no CL-
30Q02-2) were acquired from BioPal, Biophysics Assay 
Laboratory Inc (Worcester, MA). A phospholipids assay 
kit was purchased from Rolf Greiner BioChemica GmbH 
(Flacht, Germany); potassium thiocyanate (KSCN) $99%, 
per analysis was acquired from Carl Roth GmbH and Co 
(Karlsruhe, Germany); 1-(4-trimethylammoniumphenyl)-6-
phenyl-1,3,5-hexatriene p-toluenesulfonate (TMA-DPH) was 
purchased from from Invitrogen LifeTech (Carlsbad, CA); 
Agar-Agar (Kobe I) was obtained from Carl Roth GmbH and 
Co KG; and isofluorane was obtained from Abbott GmbH 
(Vienna, Austria). All other chemicals were of an analytical 
grade or of the best grade available.
Methods
Synthesis of magnetic liposomes
sMLs were prepared using a thin lipid film rehydra-
tion method. Lipids were dissolved in organic solvent 
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(chloroform:methanol = 2:1 v/v) and mixed in a molar ratio 
of 3:2:0.15 = POPC:CH:DSPE-Peg-2000 in a round-bottom 
flask. The solution was evaporated until the point of dryness 
under a stream of nitrogen, and the dry lipid film was left in a 
vacuum chamber overnight. For iron oxide nanoparticles, we 
used either an aqueous colloidal suspension of dextran-coated 
USPIOs (Molday Ion from BioPal; hydrodynamic diameter 
of 30 nm; concentration of 10 mg Fe/mL in water) or dry 
polar-coated magnetite grains (EMG 1500 from FerroTec 
Corp; nominal particle diameter of 10 nm; no specifications 
for the coating material were provided by the manufacturer). 
As the latter particles were not water soluble, we prepared 
stock solutions containing 4.3 mg of Fe/mL in butanol.
In the case of Molday-Ion USPIOs, sMLs were prepared 
by rehydrating the lipid films (10 mg of phospholipids) with 
1 mL of a HEPES buffer (20 mM of HEPES, 150 mM of 
NaCl; pH 7.4) containing different amounts of USPIOs, 
which corresponded to iron concentrations of 0.5,1.0, 2.0, and 
3.0 mg Fe/mL. During rehydration, the particles were held for 
1 hour at 40°C and vortexed intermittently to resuspend the 
lipid film completely. Subsequently, five cycles of freeze and 
thaw treatment were performed to improve the encapsulation 
of the magnetic cores into liposomes. The size of the sMLs 
was adjusted by extrusion through 200 nm polycarbonate 
membrane filters (Millipore, Billerica, MA) using a Liposo-
Fast pneumatic extruder (Avestin Inc, Ottawa, Canada). In 
the case of EMG-1500 USPIOs, the butanolic solution was 
added to the lipid film, dried under a stream of nitrogen, and 
resuspended with a HEPES buffer, as described above. Since 
EMG-1500 USPIOs stuck to the filter membrane, the extru-
sion process did not work correctly, and we had to apply a 
sonication technique to increase homogeneity. We used an AA 
Sonics Vibra-Cell Ultrasonicator (Sonics and Materials Inc, 
Newtown, CT), which we operated for 30 minutes at 130 Watts 
(30% amplitude with a pulse sequence of 30 seconds on and 
2 seconds off). Control liposomes were prepared as described 
above, but hydration was performed with 1 mL of HEPES-
buffered saline in the absence of magnetite.
Purification of stealth magnetic liposomes
Nonentrapped Molday-Ion USPIOs were separated by ultra-
filtration. A volume of about 1 mL of sMLs was applied 
in a Vivaspin 6 tube (MWCO 1000kD, polyethersulfone 
membrane; Sartorius Stedim Biotech, Göttingen, Germany) 
and centrifuged at 4°C for 40 minutes at 6000 × g with a fix-
angle rotor, using a table centrifuge (Sigma 3 K18; Sigma-
Aldrich, St Louis, MO). Washing was performed with a 
HEPES buffer; EMG-1500-loaded sMLs were   purified by 
centrifugation for 15 minutes at 1000 × g, and the supernatant 
was collected.
Chemical characterization of stealth  
magnetic liposomes
Assay of magnetite
The amounts of iron were determined photometrically 
using KSCN as follows: Aliquots of 20 µL of liposomal 
solutions before and after purification, as well as from the 
filtrate   containing the unloaded iron, were mixed with 5 µL 
of Triton X-100 [1% (v/v) in the final solution] to break the 
liposomes and release the USPIOs. A volume of 0.225 mL 
of concentrated HCl (37%) was then added to the samples to 
ionize the iron oxide crystal core and liberate the iron in its 
ferric state. The samples were incubated for a few minutes 
with 0.250 mL of a 40 mM KSCN aqueous   solution. The 
product of the reaction between the anion (SCN) and the 
Fe3+ was a red colored complex – pentaaqua(thiocyanate-N)
Fe(III), [Fe(NCS)(H2O)5]2+ – whose absorbance (ABS) at 
480 nm was read using a Hitachi model V-2000 double-beam 
UV-vis spectrophotometer (Tokyo, Japan). An aqueous solu-
tion of Fe3O4 in HCl:HEPES = 1:1 (v/v) was used to record 
a calibration curve.
Assay of phospholipids
The amount of POPC in sMLs was determined by an enzy-
matic colorimetric test, as described by the manufacturer 
(DiaSys Diagnostic Systems GmbH, Holzheim, Germany). 
Samples (10 µL) – before and after centrifugation – were 
mixed with Triton X-100 and incubated with enzymatic 
reagents for 5 minutes at 37°C, and the ABS was read at 
570 nm. The fractions containing the free USPIOs after 
purification were also analyzed to verify the absence of lipids 
in these specimens. The calibration curve was performed 
by measuring the ABS value of a phospholipid standard 
contained in the kit under the same conditions.
Determination of encapsulation efficiency (EE%)
This value designates the percentage of iron loaded into a 
liposome, and is given by the ratio between the iron concen-
tration in magnetic liposomes before and after purification 
(EE% is expressed as g Fe/mol POPC × 100).
Physical characterization of stealth magnetic 
liposomes
Particle size and zeta potential
The particle sizes of free USPIOs (EMG 1500 and Molday 
Ion), control liposomes, and sMLs were analyzed by DLS 
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using a Zetasizer 3000HS (Malvern Instruments, Herrenburg, 
Germany). To check the stability of Molday-Ion sMLs, we 
also measured the sizes of the liposomes 1 week after sample 
preparation. The zeta potential of Molday-Ion USPIOs and 
Molday-Ion sMLs was measured in a 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES) buffer using a 
Zetasizer Nano ZS (Malvern Instruments).
Particle visualization
Liposomes and USPIOs were visualized by transmission 
electron microscopy (TEM) using a Zeiss EM 902 transmis-
sion electron microscope (Oberkochen, Germany) at 80 kV 
acceleration voltage. Digital images were recovered with a 
Proscan slow scan charge-coupled device camera (IR1K, 
Moorenweis, Germany) at 1000 K × 1000 K resolution. To 
mark the liposomes, a single droplet negative staining tech-
nique was performed as follows: a drop of each specimen 
(10 µL) was placed on a Pioloform-coated carbon evapo-
rated copper grid (Plano GmbH, Wetzlar, Germany). After 
1 minute, the excess sample was removed with filter paper 
and replaced by 10 µL of staining solution consisting of 2% 
ammonium molybdate and 1% trehalose as a preservative (pH 
7.4). Finally, the samples were allowed to air dry for TEM 
visualization with a magnification of ×30000.
Fluorescence polarization (FP)
TMA-DPH is a diphenylhexatriene (DPH) derivative con-
taining a cationic trimethylammonium substituent. This 
fluorescent probe has the special property of being able 
to intercalate into the liposomal membrane, allowing the 
assessment of specific alterations in the fluidity of lipid 
assemblies.26–28
Here, we have compared sMLs to empty liposomes and 
empty liposomes just incubated with USPIOs, respectively. 
Additionally, we have investigated the impact of CH or PEG 
lipids on fluorescence polarization, using either POPC/DSPE-
Peg-2000 = 3/0.15 (mol/mol) or POPC/CH = 3/2 (mol/mol) 
formulations (10 mg/mL phospholipids), both loaded and 
unloaded with magnetite. TMA-DPH was dissolved in etha-
nol (10 mM) and further diluted with a HEPES buffer to give 
a concentration of 200 µM. TMA-DPH stock was added to 
the prediluted liposomal solutions (600 µM) to achieve a final 
fluorophore concentration in the quartz cuvette of 2 µM. The 
samples were then enveloped in aluminum foil, incubated at 
room temperature for 30 minutes, and accurately vortexed in 
the absence of direct light. Fluorescent measurements were 
carried out at 25°C using a Fluoromax-3 spectrofluorom-
eter (Jobin Yvon, Horiba, Germany) at excitation/  emission 
wavelengths set to 340/425 nm and 1.4 nm excitation and 
emission slit widths. The equation applied to calculate the 
anisotropy (,r.) of the system, which is a measure of 
molecular mobility, was as follows:
	, r. = IVV - IVH/IVV + 2IVH
where IVV is the vertically polarized excitation component 
and indicates the position of the excitation polarizer, while 
IVH corresponds to the vertical and horizontal emission 
components and denotes the emission polarizer location. 
The intensity data were corrected by subtracting the contri-
bution given by the scattering of blank samples without a 
fluorophore in the bilayer.
Magnetic resonance imaging in vitro measurements
MRI was performed with a Magnetom Tim Trio 3T machine 
(Siemens, Erlangen, Germany) using an 8-CH multipurpose 
coil (NORAS MRI products GmbH, Höchberg, Germany).
The saturation magnetizations of sMLs (0.8 mg 
POPC/mL) and free USPIOs – applied at the same iron 
concentrations as the sMLs – were measured using a suscep-
tometry method, as described by Bowen et al.29
For representative T1- and T2-weighted images, freshly 
prepared Molday-Ion sMLs and EMG-1500 sMLs were 
embedded in uniform gel suspensions (1% w/w agarose, 
1.2 mg POPC/mL) and placed into a spherical gel phantom 
in order to avoid interference produced by macroscopic 
B0 inhomogeneities.
With the strong T2 and restrictions and the shortest pos-
sible echo time in mind, we used an inversion recovery Rapid 
Acquisition with Relaxation Enhancement  to show the T1 
effect. T1-weighted images were acquired with an inversion 
time of TI = 50 ms, FOV = 70 × 100 mm, matrix = 180 × 256, 
slice thickness = 5 mm, TR = 5000 ms, TE = 11 ms, TF = 5, 
BW/pixel: 349 Hz, NSA = 1. T2-weighted images were 
acquired with a CPMG pulse sequence with echo times of 
TE = 13/26/39/52/65 ms, FOV = 81 × 100, matrix = 166 × 256, 
slice thickness = 5 mm, TR = 2000 ms, BW/pixel: 425 Hz, 
NSA = 1. In order to better visualize the differences in T2 
enhancement and to avoid complete signal loss, the first 
echo was chosen.
Animal model and ethics
All animal experiments were carried out in accordance with 
the approvals of the Ministry of Science and Research,   Austria. 
Nine wild type mice of random sex (Medical   University of 
Vienna, Austria) that weighed between 29.3 g and 33.7 g 
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were used in the biodistribution studies: three sham mice 
were used as control, while the other six were separated into 
groups of three, either for the   injection of Molday-Ion sMLs 
(between 170 µL and 190 µL,   corresponding to 50 µmol Fe/
kg body weight) or free USPIOs (equivalent in iron content 
to the sMLs). Before injection into the retro-orbital sinus 
with a 27 gauge needle, the mice were placed in an induction 
chamber and narcotized with 5% (v/v) isofluorane (ISO), 
1.5 bar/oxygen till gasping. Eight days after injection, mice 
were sacrificed via an ISO overdose; then, about 250 µL 
of total blood was collected by cardiac puncture, and the 
circulation was immediately rinsed with phosphate buffer 
saline PBS (pH 7.4) for 15 minutes by heart perfusion. The 
organs (liver and kidneys) were accurately removed, fixed 
for 30 minutes in 4% (v/v) paraformaldehyde in PBS (pH 
7.4), rinsed with PBS, shock-frozen, and stored at -80°C 
for further analysis.
Inductively coupled plasma optical emission 
spectrometry
Blood samples and weighed portions of liver and kidneys 
underwent microwave-assisted digestion in an acidic   mixture 
(3 mL of HNO3, 1 mL of HCl, 2 mL of water) until complete 
decomposition, using an Anton Paar Multiwave 3000 system 
(Anton Paar GmbH, Graz, Austria). The iron content was sub-
sequently determined via inductively   coupled plasma opti-
cal emission spectrometry (ICP-OES) with a Spectro Ciros 
Vision Optical emission spectrometer instrument (Spectro 
GmbH, Kleve,   Germany) at 1400 W RF power; 12.5 L/min 
Argon (Ar) outer gas flow; 0.6 L/min Ar intermediate gas 
flow; 0.86 L/min nebulizer gas flow; scot type spray   chamber; 
and cross-flow nebulizer. The instrument was calibrated with 
iron solutions ranging from 0 mg Fe/L to 5.0 mg Fe/L, and 
Scandium (Sc) was employed as an internal standard mea-
surement criterion for four replicates at 24 s integration; Fe 
(II) 238,204 nm was used.
Magnetic resonance imaging in vivo analysis
For the distribution study, the relative changes in the relax-
ation times of muscle, liver, and kidneys were quantified by 
quantitative relaxation time analysis after injection of either 
Molday-Ion sMLs (n = 3) or free Molday-Ion USPIOs (n = 3) 
at a dose of 50 µmol Fe/kg body weight. Measurements 
were acquired at different time points (0 minutes, 5 minutes, 
5 hours, 12 hours, 24 hours, and 7 days post injection).
In vivo T1 and T2* relaxation maps were acquired on the 
same system that was applied for the in vitro phantom studies, 
using the 8-CH multipurpose coil for high signal-to-noise 
ratio-whole body coverage of the mice. For the T1 measure-
ment, an inversion-recovery turbo-spin-echo pulse sequence 
was used: FOV = 40 × 80 mm, matrix = 64 × 128, slice 
  thickness = 1.5 mm, TR = 5000 ms, TE = 9.5 ms, TF = 7, 
BW/pixel: 349 Hz, TI = 50/200/800/2000 ms, NSA = 3. T2* 
was acquired with a 2D multi-echo gradient-echo sequence 
of 4 echoes, with the following parameters: echo spacing of 
5.5 ms, first echo = 3.9 ms, FOV = 40 × 80, matrix = 96 × 192, 
slice thickness = 1.5 mm, TR = 261 ms, BW/pixel: 491 Hz, 
NSA = 20.
Statistical analysis
Values were expressed as mean ± standard deviation (SD). 
Student’s t-test was performed to identify significant differ-
ences between samples, and P values #0.01 were assumed 
to be statistically significant. All tests were performed using 
the statistical and process management software MINITAB 
(v13.0; State College, PA).
Results and discussion
Stealth magnetic liposome purification 
and encapsulation efficiency
Immediately after extrusion/sonication, nonenclosed 
Molday-Ion and EMG-1500 USPIOs were removed by ultra-
filtration or centrifugation, respectively. Figure 1A illustrates 
the aggregation and sedimentation behavior observed for 
EMG-1500 USPIOs in colloidal suspensions of sMLs. In 
contrast, Molday-Ion USPIOs were perfectly dispersed in 
an aqueous solution without showing any aggregation or 
separation from the liposomal phase after incorporation. 
A brownish homogenous dispersion of purified Molday-Ion 
sMLs was obtained (Figure 1B).
Once sMLs were recovered and free of contaminated 
external magnetite, their iron content was determined by a 
colorimetric test using KSCN, and encapsulation efficiency 
Figure 1 Pictures of (A) sonicated liposomes loaded with polar-coated EMG-1500 
USPIOs and (B) extruded sMLs encapsulating dextran-coated Molday-Ion USPIOs.
Note: Photographs were taken a few hours after purification, and samples were 
kept at room temperature.
Abbreviation: USPIOs, ultrasmall superparamagnetic iron oxides.
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Table 1 Iron quantification via colorimetric assay using KSCN and encapsulation efficiency estimation of purified Molday-Ion sMLs
Initial iron concentration for 
sML synthesis (mg Fe/mL)
Iron concentration of sMLs before 
purification (g Fe/mol POPC)
Iron concentration of sMLs after 
purification (g Fe/mol POPC)
Encapsulation 
efficiency* (%)
0.5 57.4 ± 2.6 53.1 ± 3.8 92 ± 3.3
1.0 119.3 ± 8.9 89.6 ± 4.6 75 ± 1.8
2.0  247.4 ± 19.6  205.7 ± 22.1 83 ± 10.4
3.0  343.1 ± 46.0  252.6 ± 38.4 74 ± 4.9
Notes: *Percentage of encapsulation efficiency was calculated from the ratio of the iron concentration in sMLs before and after purification (EE% expressed as g Fe/mol 
POPC × 100). Values (±SD) are the mean of three experimental evaluations.
Abbreviations: EE%, encapsulation efficiency; POPC, 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; sMLs, stealth magnetic liposomes.
was calculated. The corresponding data are summarized in 
Table 1.
For Molday-Ion sMLs, we found that the EE% decreased 
with increasing quantities of USPIOs that were used for   
loading. Additionally, we observed the highest encapsula-
tion efficiency of 92% for the sample with the lowest initial 
iron concentration of 0.5 mg Fe/mL. This is in agreement 
with the results obtained by Sabaté et al,10 who also showed 
that the EE% is inversely proportional to the initially 
applied iron content. However, even for the sample with 
the highest initial iron concentration (3 mg Fe/mL), an EE% 
above 70% was achieved. Regardless of this fact, the absolute 
amount of iron that could be incorporated into liposomes was 
higher using higher initial amounts of USPIOs. This finding is 
in accordance with results reported by Skouras et al.30 Further 
increases in iron concentration (above 3 mg Fe/mL) did not 
improve the absolute yield (data not shown).
Additionally, we tested the stability of Molday-Ion USPIO 
sMLs 1 week after preparing and measuring the EE%. We 
found EE% values of 42%, 72%, 63%, and 65% for samples 
having initial iron concentrations of 0.5, 1.0, 2.0, and 3.0, 
respectively, indicating that the USPIOs become released 
over time.
Effective encapsulation was also confirmed by zeta 
potential measurements. Free Molday-Ion USPIOs showed 
a surface charge potential of -6.84 mV ± 0.007 mV , which 
changed to -4.41 mV ± 0.007 mV for Molday-Ion sMLs. 
This value was very similar to that of empty liposomes, which 
had a potential of -4.12 mV ± 1.10 mV .
Varying results were obtained for EMG-1500 sMLs, depend-
ing on the amount of nonentrapped iron after   centrifugation. 
This value was extremely high, and only very low encapsulation 
efficiencies of 3% and 18% were accomplished using initial 
iron concentrations of 3.0 and 0.5 mg Fe/mL, respectively. 
Nevertheless, the highest EE% was again achieved for the 
lowest initial quantity of iron used.
The deviating behavior of the two commercially available 
USPIOs, with respect to encapsulation, could be due to 
differences in the structure of the crystal bulk. Different methods 
of synthesis, reaction conditions, or a different Fe2+:Fe3+ ratio can 
generate variable magnetic cores of various sizes that contain 
one or more iron oxides.31 Moreover, the type, arrangement, 
and efficiency of the coating material on the iron oxide nano-
cores could modulate not only the magnetic properties and the 
relaxivity values of the nanoparticles, but also their stability and 
solubility properties, thereby influencing entrapment efficacy.
Diameter and morphology of ultrasmall 
superparamagnetic iron oxides and stealth  
magnetic liposomes
DLS experiments revealed an average hydrodynamic 
diameter for the dextran-coated Molday-Ion USPIOs of 
23.8 nm ± 0.4 nm and a polydispersity index (PDI) of 
0.20 ± 0.01 (n = 3). These values are in line with data provided 
by the manufacturer. Extruded Molday-Ion-loaded sMLs 
and empty control liposomes exhibited mean hydrodynamic 
diameters between 160 nm and 170 nm (PDI = 0.10 ± 0.01). 
Notably, the average diameter size of sMLs was not signifi-
cantly influenced by increasing the initial amount of USPIOs, 
and the particle size remained constant for at least 1 week of 
storage at room temperature.
In contrast, the size distribution observed for the polar-
coated EMG-1500 USPIOs was very broad. The EMG-1500 
USPIOs were highly heterogeneous in colloidal suspension 
and revealed diameters ranging from 100 nm to 1000 nm with a 
PDI value of 0.8 ± 0.2. This size – in terms of   inhomogeneity – 
is most probably the reason why EMG-1500 USPIOs could 
not be sufficiently incorporated into liposomes. After soni-
cation, EMG-1500-loaded sMLs revealed a hydrodynamic 
diameter between 100 nm and 130 nm (PDI = 0.1 ± 0.005). 
A similar size distribution was found for sonicated empty 
liposomes that we used as the control.
To visualize USPIOs, we used TEM (Figure 2); with TEM, 
we could also observe the iron oxide grains (dark spots), which 
were tightly packed within Molday-Ion-loaded sMLs, whereas 
the liposomes were observed as closed quasi-spherical struc-
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Figure 2 TEM micrographs of (A) dextran-coated Molday-Ion USPIOs (1.7 mg Fe/mL) in an aqueous buffer directly observed under the microscope; (B) sMLs loaded with 
Molday-Ion USPIOs at a final iron concentration of 1.7 mg Fe/mL (after extrusion and purification); and (C) extruded control liposomes without magnetite.
Abbreviations: sMLs, stealth magnetic liposomes; TEM, transmission electron microscope; USPIOs, ultrasmall superparamagnetic iron oxides.
tures, most of which had a diameter of less than 200 nm. Due 
to the poor performance of EMG-1500-loaded liposomes, 
they were not further investigated by TEM.
Fluorescence polarization
To investigate whether the incorporation of Molday-Ion 
USPIOs in liposomes has any influence on phospholipid 
bilayer properties, we performed anisotropy measurements 
to monitor lipid membrane fluidity.
To this end, the fluorescence polarization of the 
amphiphilic fluorophore TMA-DPH – which preferentially 
locates close to the polar head group region of the lipid 
bilayer and probes the water-lipid interface – was recorded. 
We found a significant increase in the ,r. values from 
0.241 ± 0.003 to 0.275 ± 0.010 (P , 0.01) by comparing 
empty liposomes with purified sMLs that contained a final 
iron concentration of 1.7 mg/mL. In contrast, incubation of 
preformed empty liposomes with Molday-Ion USPIOs with 
the same iron concentration of 1.7 mg/mL did not show a 
notable shift of the anisotropy value (,r. = 0.248 ± 0.002), 
compared to empty control liposomes. These data suggest 
that USPIOs primarily interact with the lipid membrane when 
they are entrapped into the liposomes. One possible explana-
tion for this behavior is that high concentrations of USPIOs 
are confined to a small volume of water inside the liposomes 
and most probably interact with the hydrophilic phospholipid 
head groups in the inner leaflet of the bilayer, causing rigidi-
fication of the bilayer itself. Further evidence in support of 
this notion comes from experiments on formulations without 
CH or PEG lipids. As expected, these formulations were more 
fluid than our lead formulation that contained both DSPE-
Peg-2000 and CH, but again, the anisotropy value increased 
upon the incorporation of USPIOs (see Table 2). In contrast, 
when dextran-coated USPIOs are freely dispersed in water, 
they have no impact on lipid membranes.
Table 2 Anisotropy values (,r.) of empty and Molday-Ion-
loaded sMLs of different lipid compositions
Liposome  
formulation
Lipid molar  
ratio (mol/mol)
CFe in sMLs  
(mg/mL)
Anisotropy
POPC/CH/Peg 3/2/0.15 –      0.241 ± 0.003
POPC/CH/ 
Peg/Fe
3/2/0.15 1.7  0.275* ± 0.013
POPC/CH/ 
Peg + Fe
3/2/0.15 1.7 0.248** ± 0.002
POPC/Peg 3/0.15 –    0.184 ± 0.010
POPC/Peg/Fe 3/0.15 1.7  0.202* ± 0.004
POPC/CH 3/2 –      0.203 ± 0.003
POPC/CH/Fe 3/2 1.0    0.258* ± 0.009
Notes:  Anisotropy  values  are  presented  as  mean  ±  SD  of  three  experiments. 
*In all cases, sMLs showed a significantly increased anisotropy compared to the 
corresponding empty formulation (P , 0.01). **Subsequent incubation with free 
USPIOs caused no significant increase in anisotropy (P . 0.01).
Abbreviations:  sMLs,  stealth  magnetic  liposomes;  POPC,  1-Palmitoyl-2-oleoyl-
sn-glycero-3-phosphocholine; CH, cholesterol; Peg, polyethylene glycol; CFe, iron 
concentration.
Magnetic resonance imaging in vitro and in vivo
In vitro measurements revealed that the magnetization 
curves determined for free USPIOs and Molday-Ion sMLs 
have similar shapes (Figure 3). In this diagram, the values 
for saturation magnetization are reported in emu/cm3, as 
a function of the Fe concentration (mg/mL). The similar 
behavior of the magnetization curves demonstrates that the 
superparamagnetic properties of the iron oxide nanoparticles 
are preserved after encapsulation in liposomes.
Next, we compared the positive and negative signal 
enhancement – visualized on T1- and T2-weighted images in 
agarose gel phantoms – which contained either Molday-Ion 
or EMG-1500 USPIO-loaded liposomes.
For this purpose, we used sMLs that were freshly prepared 
at the same lipid concentration, but with increasing amounts of 
iron. Due to the different encapsulation efficiencies, the actual 
concentration of iron in sMLs was lower, especially for the 
EMG-1500 sMLs. These discrepancies in iron   concentrations 
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Figure 3 Saturation magnetization values (emu/cm3) of Molday-Ion sMLs compared to free Molday-Ion USPIOs, as a function of the Fe concentration (mg/mL).
Note: The points on the diagram represent the mean value of three experiments (±SD).
Abbreviations: sMLs, stealth magnetic liposomes; USPIOs, ultrasmall superparamagnetic iron oxides.
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Figure 4 T2-weighted image (A) and T1-weighted scan (B) of either Molday-Ion sMLs (upper part in panels A and B) or EMG-1500sMLs (lower part in panels A and B) in 
1% agarose gel phantoms.
Notes: The final CFe (mg/mL) values correspond to the actual concentrations used for the MRI measurements shown here. Agarose gel and empty liposome are the control 
samples used as a reference.
Abbreviations: sMLs, stealth magnetic liposomes; CFe, iron concentration; MRI, magnetic resonance imaging; agar, agarose gel; EL, empty liposome; ctrl, control.
sMLs Phantom  
preparations
Molday lon-/ EMG 1500-sMLs 
initial CFe (mg/mL)
Molday lon-sMLs 
final CFe (mg/mL)
EMG 1500-sMLs  
final CFe (mg/mL)
1 0.5 0.4 0.09
2 1.0 0.8 0.13
3 2.0 1.7 0.15
4 3.0 2.7 0.08
were clearly visible in both T1 and T2 scans, as shown in 
Figure 4. The signal intensities of the MR scans correlated 
very well with the actual iron   concentrations. For Molday-
Ion USPIO sMLs, we found that the higher the iron loading, 
the better the contrast enhancement; the signal recorded 
from the EMG-1500 sMLs was always low due to inefficient 
encapsulation and low effective iron concentration.
Based on the in vitro results, Molday-Ion-loaded sMLs 
were chosen as MRI probes for in vivo experiments, in which 
we studied the biodistribution of sMLs relative to free USPIO 
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Figure 5 Behavior of the kidneys, liver, and muscle.
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Figure 6 Relative changes in relaxation times (qT1, qT2*) of muscle, liver, and kidneys after injection of clinical doses of 50 µmol Fe/Kg body weight in wild type mice.
Notes: Signal changes were acquired at different time points (0 minutes, 5 minutes, 5 hours, 12 hours, 24 hours, 7 days) after administration of sMLs (A and C) and Molday-
Ion USPIOs (B and D), respectively. A strong signal reduction was observed in liver and kidneys for both sMLs and USPIOs 5 minutes after sample administration. No visible 
change was measured in the muscles.
Abbreviations: sMLs, stealth magnetic liposomes; USPIOs, ultrasmall superparamagnetic iron oxides; h, hours; d, days.
nanoparticles. T1 and T2* organ maps were recorded in dif-
ferent tissues after injection of either of the sMLs (Figure 5, 
panel A I-III) or free USPIOs (Figure 5, panel B I-III) in wild 
type mice. The images qualitatively illustrated the signal 
behavior of kidneys, liver, and muscle scanned before and 
at different time points after sample administration; sMLs 
showed a biodistribution similar to free Molday-Ion USPIOs. 
Both induced a contrast enhancement in the kidneys and liver, 
lasting for at least 5 hours. This similarity in in vivo turnover 
rates could partially be explained by the surface characteris-
tics of dextran-coated USPIO colloids and sMLs, both having 
a polymer around the core – ie, dextran in the case of USPIOs 
and a PEG coat in case of sMLs. The   surface coating is very 
important in the way of prolonging the circulation time of 
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nanoparticles in the blood, thus evading the immune system 
more efficiently.23–25
Next, we determined the relative changes in T1 and T2* 
relaxation times via quantitative analysis. These results 
are reported in Figure 6, where the relative organ signal 
  intensities (SI) are expressed as T1 post/T1 pre and T2* post/
T2* pre ratios, and the accumulation behavior of either of 
the sMLs (a, c) or free USPIOs (b, d) are shown.
Strong signal reduction was measured for sMLs and 
USPIOs in liver and kidneys on both T1 and T2* sequences, 
and 1 week later, the signal went back to the baseline level, 
which corresponds to the value before sample injection. In 
the liver, 5 minutes after injection, we found percentage 
reductions of 55% and 48% in the T1 relaxation time for 
sMLs and free iron oxides, respectively. After 24 hours, these 
values were equivalent to 30% and 20% reductions in T1. 
Also, with respect to T2* relaxation time, high reductions 
of 80% and 90% were achieved in the liver 5 minutes after 
injection of either sMLs or free Molday-Ion USPIOs, and 
these values were still pronounced 24 hours later (74% for 
sMLs and 70% for free USPIOs). No signal reduction was 
detected in the muscles, indicating that the particles do not 
penetrate the vessel wall, and this gives the advantage of 
using the muscles as reference regions of signal normaliza-
tion in semi-quantitative analysis.
After 7 days, sMLs and free USPIOs were completely 
cleared by the circulation system, as well as the kidneys, as 
confirmed by ICP-OES quantification (Figure 7). However, 
a higher accumulation of iron was detected in the livers 
of animals, which were treated with sMLs instead of free 
USPIOs. Taken together, our long-term MRI investigations 
revealed that free USPIOs and sMLs display a similar tem-
poral tissue distribution. Both preferentially accumulated in 
the liver, whereas sMLs seemed to get cleared more slowly. 
Here, it has to be mentioned that with MRI imaging and 
ICP-OES quantification, we cannot distinguish between intact 
USPIO-loaded sMLs and USPIO nanoparticles released 
from liposomes. Although, from our in vitro experiments, 
we know that more than 75% of USPIOs remain in the sMLs 
upon storage for 1 week; the situation in vivo will certainly 
be different.
Conclusion
The purpose of our study was to synthesize and characterize 
sMLs with adequate properties for MRI using commercially 
available USPIOs. We could demonstrate that not all types 
of USPIOs are suitable for encapsulation in liposomes. We 
found that a maximum threshold concentration of USPIOs 
could be encapsulated into unilamellar liposomes with 
a mean particle diameter of less than 200 nm. We could 
also show that this USPIO concentration is sufficient to 
produce a pronounced signal enhancement in MRI in vitro 
and in vivo. Taken together, we have established a robust, 
sterically stabilized ML formulation with efficient MRI 
contrast properties for functional imaging. Currently, our 
studies are directed toward the targeting potential of such 
sMLs to enable their application in diagnostic medicine, 
with a specific focus on cardiovascular diseases, such as 
atherosclerosis.
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